What's New
Millennial Whose Father Has PSP Explains the Challenges Faced by Millennial Caregivers
When Jennifer N. Levin’s father was diagnosed with progressive supranuclear palsy, she was only 32 and living across the country, working long hours at her job in the television industry.…
AFTD Ambassador Shares Husband’s FTD Journey with West Virginia Newspaper
In a May 21 article published in the Charleston Gazette-Mail, AFTD Ambassador Debbie Elkins detailed her family’s FTD journey following the diagnosis of her husband, Chuck. She recounted the first…
AFTD Medical Advisor Emeritus Virginia Lee Elected to National Academy of Sciences
Virginia M.-Y. Lee, PhD, an emeritus member of the AFTD Medical Advisory Council (MAC) and the current director of the University of Pennsylvania’s Center for Neurodegenerative Disease Research, was elected…
Emma Heming Willis Honored with Caregiving Award
Emma Heming Willis was recently honored by Maria Shriver’s Women’s Alzheimer’s Movement (WAM) at Cleveland Clinic, receiving the organization’s Caregiving Award for her “outstanding work in advocating for unpaid family…
Session Videos from AFTD’s 2025 Education Conference Now Available
Sessions from AFTD’s 2025 Education Conference are now available on our YouTube channel. Whether you missed a session, you weren’t able to join us live in Denver or virtually, or…
Study Identifies Profile of Blood-Based Inflammatory Proteins as Potential FTD Biomarker
A study published in the journal Brain earlier this year identified a profile of inflammation-related proteins that could potentially serve as a FTD biomarker gauging the severity of the disease.…
Tips & Advice – Navigating FTD-ALS
In 2011, researchers discovered that variants of the C9orf72 gene are the most common cause of both genetic FTD and amyotrophic lateral sclerosis (ALS). Nevertheless, it is important to recognize…
Coya Therapeutics Reports Positive Interim Results in Clinical Trial for Experimental FTD Therapy
Coya Therapeutics announced positive interim results for its clinical trial for a potentially disease-modifying treatment course for FTD, citing data showing that it helped to prevent cognitive decline. Therapeutics Address…
AviadoBio Announces Completion of Second Cohort in ASPIRE-FTD Trial at AFTD Education Conference
Gene therapy company AviadoBio announced the completion of the second cohort of its phase 1/2 clinical trial of a potential genetic FTD treatment at the 2025 AFTD Annual Education Conference…
Celebrating 20 Years of AFTD’s Pilot Grant Program
Over the past 20 years, AFTD’s Pilot Grant program, which supports early-career researchers or new ideas, has funded $2.8 million in innovative FTD research. In 2005, AFTD founder Helen-Ann Comstock…
English 
Spanish (Mexico) 
French 
German 
Swedish 
Portuguese 
Italian 
Dutch 
Danish 
Polish 
Spanish (Spain) 
English